.NAPSRX FULL SOLUTION PACK WITH
COMPLETE SOLUTIONS (Everything you
need to get a clean A)
NAPSRX PRACTICE QUESTIONS- TEST PREP
Quiz 1 , Chapter 1
1. Pharmaceuticals are arguably the most socially important healthcare product.
i. TRUE
ii. FALSE
2. Pharmaceutical development is a high-risk undertaking, in which many promising leads
prove disappointing.
i. TRUE
ii. FALSE
3. Pharmaceutical sales are highest in which geographical regions?
i. The U.S., Saudi Arabia, and Japan
ii. The U.S., Western Europe, and Japan
iii. Western Europe, Australia, and Canada
iv. Western Europe, Canada, and Saudi Arabia
4. The U.S. accounts for about of the world’s pharmaceutical revenues.
i. 30%
ii. 50%
iii. 80%
iv. 95%
5. Which of the following has fueled recent growth in the pharmaceutical industry?
i. increased international standardization and regulation
ii. international legalization of DTC advertising
iii. population growth and increased life expectancies
iv. all of these
6. According to your manual, which statement accurately describes the predicted relationship between
pharmaceutical companies and genomic research facilities?
i. "Genomic research company" is another term for "ethical research company."
ii. Partnerships between pharmaceutical companies and genomic companies will not prove
immediately profitable.
iii. Pharmaceutical companies have little to no interest in partnerships with genomic research companies.
iv. Pharmaceutical companies will be genomic research companies' biggest competitors in the coming years.
7. Prescription drug therapy is not cost-effective for insurance companies and healthcare providers.
i. TRUE
, ii. FALSE
8. The high price of healthcare is explained by the high price of medicines.
i. TRUE
ii. FALSE
9. One of the oldest and least effective pharmaceutical marketing techniques is DTC (direct-to-consumer)
advertising.
, i. TRUE
ii. FALSE
10. What influences the number of districts in a region?
i. the number of qualified sales representatives who apply to represent that region
ii. the region's population
iii. both the district's population and the number of qualified sales representatives who apply to represent
that region
iv. none of these
11. What is an example of the regionalization of healthcare delivery systems?
i. California and Florida have different demographics.
ii. California and Florida have different drug companies.
iii. California and Florida have different DTC advertisements.
iv. California and Florida have different prescription reimbursement policies.
12. The heart of a pharmaceutical sales team is the Regional Manager.
i. TRUE
ii. FALSE
13. Most DMs did not start as representatives.
i. TRUE
ii. FALSE
14. How many territories are in a typical district?
i. 1 to 2
ii. 8 to 12
iii. 30 to 40
iv. 50 to 100
15. What is the most effective method for grabbing market share?
i. comparative selling
ii. criticizing the competition
iii. power point presentations
iv. questioning doctors' choices
Quiz 2 , Chapter 2 & 3
1. Pharmaceutical reps mainly visit pharmacies.
i. TRUE
ii. FALSE
2. It usually only takes 1-2 calls to a physician before he or she commits to prescribing your product.
i. TRUE
ii. FALSE
3. The pharmacist may dispense a product other than what the physician prescribed
, i. TRUE
ii. FALSE
4. According to Chapter 12 of your manual, which of the following would classify as "payers"?
i. employers
ii. patients
iii. pharmacists
iv. physicians
5. According to your manual, what defines "ethical pharmaceutical companies"?
i. donating a specified proportion of their revenue to consumer organizations
ii. donating a specified proportion of their revenue to the NIH
iii. manufacturing generics
iv. researching and developing novel drugs
6. One of the most disappointing results of the pharmaceutical industry’s continued investment in R & D is
the few new drugs being approved and in development.
i. TRUE
ii. FALSE
7. Thanks to modern medicines, how long are people newly diagnosed with HIV expected to live?
i. another 10 years
ii. another 20 years
iii. another 5 years
iv. another 50 years
8. How much has the average American lifespan increased since 1890?
i. almost 10 years
ii. almost 15 years
iii. almost 30 years
iv. almost 5 years
9. What is a treatment group?
i. a group of patients assigned to receive a specified treatment
ii. a group of patients who have volunteered to receive the active drug, but not the placebo
iii. A group of substances being tested
iv. A list of study protocols
10. What is the main difference between a blinded and double-blinded study?
i. A blinded study is performed to control the placebo effect whereas a double-blinded study is performed
to control the observer effect.
ii. A double-blinded study has two control groups, but a blinded study only has one.
iii. Blinded studies are more scientifically rigorous.
iv. In a double blinded study, neither the study staff nor the study participants know which
subjects are in the experimental group and which are in the control.
11. What does "asymptomatic" mean?
i. exhibiting atypical signs or symptoms that were not indicated in the product packaging
ii. not exhibiting signs or symptoms
COMPLETE SOLUTIONS (Everything you
need to get a clean A)
NAPSRX PRACTICE QUESTIONS- TEST PREP
Quiz 1 , Chapter 1
1. Pharmaceuticals are arguably the most socially important healthcare product.
i. TRUE
ii. FALSE
2. Pharmaceutical development is a high-risk undertaking, in which many promising leads
prove disappointing.
i. TRUE
ii. FALSE
3. Pharmaceutical sales are highest in which geographical regions?
i. The U.S., Saudi Arabia, and Japan
ii. The U.S., Western Europe, and Japan
iii. Western Europe, Australia, and Canada
iv. Western Europe, Canada, and Saudi Arabia
4. The U.S. accounts for about of the world’s pharmaceutical revenues.
i. 30%
ii. 50%
iii. 80%
iv. 95%
5. Which of the following has fueled recent growth in the pharmaceutical industry?
i. increased international standardization and regulation
ii. international legalization of DTC advertising
iii. population growth and increased life expectancies
iv. all of these
6. According to your manual, which statement accurately describes the predicted relationship between
pharmaceutical companies and genomic research facilities?
i. "Genomic research company" is another term for "ethical research company."
ii. Partnerships between pharmaceutical companies and genomic companies will not prove
immediately profitable.
iii. Pharmaceutical companies have little to no interest in partnerships with genomic research companies.
iv. Pharmaceutical companies will be genomic research companies' biggest competitors in the coming years.
7. Prescription drug therapy is not cost-effective for insurance companies and healthcare providers.
i. TRUE
, ii. FALSE
8. The high price of healthcare is explained by the high price of medicines.
i. TRUE
ii. FALSE
9. One of the oldest and least effective pharmaceutical marketing techniques is DTC (direct-to-consumer)
advertising.
, i. TRUE
ii. FALSE
10. What influences the number of districts in a region?
i. the number of qualified sales representatives who apply to represent that region
ii. the region's population
iii. both the district's population and the number of qualified sales representatives who apply to represent
that region
iv. none of these
11. What is an example of the regionalization of healthcare delivery systems?
i. California and Florida have different demographics.
ii. California and Florida have different drug companies.
iii. California and Florida have different DTC advertisements.
iv. California and Florida have different prescription reimbursement policies.
12. The heart of a pharmaceutical sales team is the Regional Manager.
i. TRUE
ii. FALSE
13. Most DMs did not start as representatives.
i. TRUE
ii. FALSE
14. How many territories are in a typical district?
i. 1 to 2
ii. 8 to 12
iii. 30 to 40
iv. 50 to 100
15. What is the most effective method for grabbing market share?
i. comparative selling
ii. criticizing the competition
iii. power point presentations
iv. questioning doctors' choices
Quiz 2 , Chapter 2 & 3
1. Pharmaceutical reps mainly visit pharmacies.
i. TRUE
ii. FALSE
2. It usually only takes 1-2 calls to a physician before he or she commits to prescribing your product.
i. TRUE
ii. FALSE
3. The pharmacist may dispense a product other than what the physician prescribed
, i. TRUE
ii. FALSE
4. According to Chapter 12 of your manual, which of the following would classify as "payers"?
i. employers
ii. patients
iii. pharmacists
iv. physicians
5. According to your manual, what defines "ethical pharmaceutical companies"?
i. donating a specified proportion of their revenue to consumer organizations
ii. donating a specified proportion of their revenue to the NIH
iii. manufacturing generics
iv. researching and developing novel drugs
6. One of the most disappointing results of the pharmaceutical industry’s continued investment in R & D is
the few new drugs being approved and in development.
i. TRUE
ii. FALSE
7. Thanks to modern medicines, how long are people newly diagnosed with HIV expected to live?
i. another 10 years
ii. another 20 years
iii. another 5 years
iv. another 50 years
8. How much has the average American lifespan increased since 1890?
i. almost 10 years
ii. almost 15 years
iii. almost 30 years
iv. almost 5 years
9. What is a treatment group?
i. a group of patients assigned to receive a specified treatment
ii. a group of patients who have volunteered to receive the active drug, but not the placebo
iii. A group of substances being tested
iv. A list of study protocols
10. What is the main difference between a blinded and double-blinded study?
i. A blinded study is performed to control the placebo effect whereas a double-blinded study is performed
to control the observer effect.
ii. A double-blinded study has two control groups, but a blinded study only has one.
iii. Blinded studies are more scientifically rigorous.
iv. In a double blinded study, neither the study staff nor the study participants know which
subjects are in the experimental group and which are in the control.
11. What does "asymptomatic" mean?
i. exhibiting atypical signs or symptoms that were not indicated in the product packaging
ii. not exhibiting signs or symptoms
